tiprankstipranks
Outlook Therapeutics (DE:41O)
NASDAQ:41O
41O
Outlook Therapeutics
RESEARCH TOOLSreports

Outlook Therapeutics (41O) Revenue

7 Followers
StatisticsMarket CapRevenue

Outlook Therapeutics Revenue

Outlook Therapeutics had a revenue of 127.44K in the quarter ending Mar 31, 2026, with 110.55%. This bring the company's revenue in the last twelve months to 333.14K, Decreased 61.95%. In the fiscal year ending Sep 30, 2025, Outlook Therapeutics had annual revenue of 1.41M with Infinity% growth.
Revenue (ttm)
333.14K
Revenue Growth
―
P/S Ratio
59.62
Revenue/Employee
€61,458
Employees
23
Market Cap
€84.28M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2025
1.41M―+∞%
Sep 30, 2024
―――
Sep 30, 2023
―――
Sep 30, 2022
―――
Sep 30, 2021
―――
Sep 30, 2020
―-8.15M-100.00%
Sep 30, 2019
8.15M5.06M+163.80%
Sep 30, 2018
3.09M-724.00K-18.99%
Sep 30, 2017
3.81M――